Observational Study of Effect of Radiation Therapy to Immuno Status in HIV-cancer Patients
Overview
Objectives: To study immunostatus (CD4) and HIV viral load in HIV-cancer patients before RT and last weeks of RT .
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
Interventions
- Radiation: Radiation therapy
- External photon beam radiation therapy dosage 4000-7000 CGy
- Other: Venepuncture
- Venepuncture for CD4 and viral load count at Week 0, Last week of Radiation, and 12, 24 Week follow up
Arms, Groups and Cohorts
- HIV-cancer patients who recived RT
Participating in This Clinical Trial
Inclusion Criteria
- Age 18-65 years – HIV positive cancer patients – Photon beam RT, conventional fraction >= 4000 cgy in 4 weeks Exclusion Criteria:
- CD4 count < 200 cell/ml and not received anti retro viral
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: 65 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Rajavithi Hospital
- Provider of Information About this Clinical Study
- Sponsor
- Overall Contact(s)
- Pathomphorn Siraprapasiri, MD, 66-89-6662960, spathomphorm@gmail.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.